Career Awards for Medical Scientists

Application Deadline

Oct 07, 2025

Status

Not Open to Applications

Grant Information

The Career Awards for Medical Scientists (CAMS) is a highly competitive program that provides $700,000 awards over five years for physician-scientists, who are committed to an academic career, to bridge advanced postdoctoral/fellowship training and the early years of faculty service.

Award Information

For more information about the CAMS award, please view this webinar recording from the 2024-2025 application cycle. In this webinar, CAMS Program Officer Dr. Paige Cooper Byas provided an overview of the application process, eligibility, and award components.

Any dates mentioned in this recording refer to the 2024-2025 application cycle. For updated deadline and notification dates, please see the 2025-2026 RFP.

Progress Reporting

Progress and financial reports are required of all BWF grants and are due on the date(s) specified in ProposalCentral. Advisory Committee and staff depend heavily upon progress and financial reports to evaluate progress. Late reports inconvenience advisory committee reviewers and impede BWF's evaluation of its programs. Failure to submit progress or financial reports in a timely fashion will result in payments being withheld, and if submissions are missed repeatedly, will result in termination of the award.

BWF provides the following progress report guidelines below to assist in the preparation and submission of Progress Reports in an acceptable manner. The progress report and financial updates are to be submitted through Proposal Central. You can find required deliverables listed on the home page after logging in to Proposal Central. Failure to submit any portion of the report by the due date will result in an interruption or cancellation of your funds.

Progress Reporting for Awardees

Progress Report

The progress report requires the awardee to submit a written report on the progress of the original or approved update to research project aims, an updated biographical sketch, a letter of support, and any recent publications. Details regarding each section are in Proposal Central. The progress report must be submitted annually on November 1st.

Financial Report

Awardees are required to update award spending in the Proposal Central budget summary. Awardees should update the financial report twice each year and provide up-to-date spending information from the previous six months. Details regarding financial reporting can be found in Proposal Central. Financial reports are due biannually on February 1st and August 1st.

Report Format

All progress and financial reporting materials should be submitted through Proposal Central. If you have questions, please contact Lama Haidar (lhaidar@bwfund.org).

Forms:

   

Eligibility

Can I contact BWF to determine my eligibility?
It is the responsibility of applicants to read the published guidelines and FAQs to determine eligibility before contacting BWF staff. If you have questions, a unique training path, or experiences that are not fully addressed, you may contact the CAMS team (cams@bwfund.org) for guidance.

The FAQs are updated regularly in response to questions received. BWF staff will do their best to respond to every inquiry but will prioritize questions not already clearly addressed in the published guidelines. Please do not contact BWF to request an exception to clearly stated guidelines.


Do I need to be nominated by my institution to apply?
No, you do not need to be nominated; however, you must obtain approval from your institution. Since August 2015, eligible candidates may now self-nominate by submitting a full proposal by the deadline. All applications must be approved by an official at the institution responsible for sponsored programs (generally from the grants and contracts office, the office of research, or the sponsored programs office).


I hold a Ph.D. degree only.Am I eligible to apply to the CAMS program?
No. If your background is in the physical/mathematical/computational sciences or engineering and your work addresses biological questions, you may want to consider applying to BWF’s Career Awards at the Scientific Interface.


I hold a Pharm.D. or Pharm.D, Ph.D. degree. Am I eligible to apply to the CAMS program?
No.


Is 75 percent of the time devoted to researching a firm policy?
Yes. Programs and department chairs must provide adequate protection for the candidate to conduct research.


As a surgeon scientist can I be considered with less than 75% research effort?
No, currently for the CAMS award the 75% effort is the expectation regardless of specialty. However, if you do not currently have 75% protected time towards research, but it can be negotiated if CAMS were awarded, you may proceed with your application. Please ensure a letter of support or offer letter can demonstrate this in writing before proceeding.


Am I required to have 75% protected research time when applying?
No, however it is the expectation that you can demonstrate that this time can be negotiated if CAMS is awarded either in letters of recommendation or an offer letter.


I may be changing institutions to complete additional postdoc training after I submit a proposal. Can I submit one?
No. Invitations to finalists are based on the information submitted in the proposal. The training environment (mentor and institution) is an integral part of this consideration and, therefore, cannot be changed after submitting the proposal. Thus, if you move to a new institution after submitting the proposal, you will not be eligible to interview, even if you are invited.


If I have an NIH K08, K12, K21, or K23 award, am I eligible for the award?
Yes.


If I have an NIH K99/R00 or Early Independence award, am I eligible for the award?
No.


I have applied to the NIH K99 and/or NIH DP5 programs, but the awards have not been selected. Can I apply to the BWF CAMS program?
Yes. However, awardees cannot receive funding simultaneously from both a K99 or DP5 and a CAMS award.


My title is instructor, clinical lecturer, or assistant professor, non-tenure track. Am I eligible for the award?
Yes, if your junior faculty appointment is non-tenure track, and you meet all other eligibility criteria, you are eligible.


How much is considered a “substantial” startup for a non-tenure track package?
BWF currently reviews non-tenure track offers on a case-by-case basis. To be considered for eligibility, please submit your full offer letter - including all details of any research startup package - to the BWF CAMS team (cams@bwfund.org) no later than 2 weeks prior to the application deadline.

You may redact any salary or confidential portions you need or prefer to keep private. Your letter will be kept confidential and only used for review of eligibility.


I have submitted a first-author manuscript from my graduate (or undergraduate) studies, but it has not yet been published.  Am I eligible to apply?
Possibly. If the manuscript is accepted for publication or in press, you can apply; otherwise, you are not eligible. BioRxiv pre-prints do count and can be included.


I have publications from my graduate (and undergraduate) studies, but I am not the first author of any of them.  Am I eligible to apply?
No. You must have at least one first-author publication to be competitive and eligible to apply for this program. This includes papers on which "first authorship" is shared.


 My field is health services research and policy. Am I eligible for the award?
No. The award is only for individuals in basic biomedical, disease-oriented, or translational research.


Do I need a commitment from a university for a faculty appointment to apply for this award?
No. The award aims to help postdoctoral scientists obtain a faculty appointment at a degree-granting institution of their choosing. Candidates may be applying for faculty positions at the same time of application, but if you currently hold or have accepted, either verbally or in writing, a tenure-track faculty appointment, you are not eligible.


I have not yet decided whether to pursue a full-time research career as an independent investigator at a North American degree-granting institution. Can I apply to this program?
Possibly. As of 2024, public or private non-profit organizations in the United States and Canada, including degree-granting academic institutions, research institutes, and teaching hospitals affiliated with academic degree-granting institutions, are eligible to receive Burroughs Wellcome Fund support.


My clinical degree was awarded outside of the US and Canada. Am I still eligible to apply?
Yes


 I am based at a North American non-profit institution, but my primary postdoctoral mentor or faculty sponsor doesn't hold a faculty appointment at an accredited, degree-granting North American institution. Can I apply to this program?
Yes. Public or private non-profit organizations in the United States and Canada, including degree-granting academic institutions, research institutes, and teaching hospitals affiliated with academic degree-granting institutions, can receive Burroughs Wellcome Fund support.

Applications from other nonprofit organizations may be considered subject to program officer approval.


I currently hold a BWF award.  Am I eligible for this award?
Possibly. Contact the program team via email to discuss eligibility.


I am a past BWF grant recipient. Am I eligible for this award?
Possibly. Contact the program team via email to discuss eligibility.


I am at an independent research institute. Am I eligible for this award?
Yes. Public or private non-profit organizations in the United States and Canada, including degree-granting academic institutions, research institutes, and teaching hospitals affiliated with academic degree-granting institutions, can receive Burroughs Wellcome Fund support.

Applications from other nonprofit organizations may be considered subject to program officer approval.


If not awarded, can candidates resubmit their applications in the future?
BWF does not currently have a cap on reapplying. As long as a candidate remains eligible, they can reapply in a future cycle(s) an unlimited number of times.

In prior RFPs candidates could not be more than 13 years past their clinical doctorate degree. Is that still true? No, the 13-year limit post clinical degree has been replaced to focus on career stage window rather than years to degree.

Proposal

Can I have a co-investigator on this proposal?
No. The CAMS grant program does not allow co-investigators.


I have two postdoctoral mentors. Can I submit two mentor recommendation letters?
Only one mentor letter of recommendation may be submitted with your proposal application. This letter should be from the person designated as your primary postdoctoral mentor or faculty sponsor in the application.

If you have a co-mentor/secondary mentor, and if both your primary and secondary mentor wish to co-write and sign one mentor letter, that is also acceptable.

Alternatively, if you have a co-mentor/secondary mentor and they would like to write one of your three additional recommendation letters, that is also acceptable.


Can support letters be sent separately outside the grant application?
No. All support letters must be uploaded and attached to your application and submitted electronically by the application deadline. Emailed, mailed, or faxed letters will not be accepted.


To whom should my letters of recommendation be addressed?
Letters of recommendation should be addressed to the CAMS Advisory Committee and must be uploaded and attached to your application and submitted electronically by the application deadline. Emailed, mailed, or faxed letters will not be accepted.


If I attach a bibliography to my research plan, does it count toward the six-page maximum?
No. Also, glossaries of technical abbreviations and terms are acceptable and encouraged if they clarify the proposal to the general reader and do not count toward the page limit.  


Are figures, tables, graphs, diagrams, and pictures included in my research plan counted in the six-page limit, or can they be included separately?
Yes, all figures, tables, graphs, diagrams, pictures, etc., included in your research plan count toward the six-page limit.  


I would like to include additional materials as appendices to the application. Is this allowed?
No. You may not include materials beyond those requested by the application instructions.  Including additional materials may disqualify you from the competition.  


Do I need to submit a proposed budget with my application?
Yes, a tentative budget associated with your project plan must be included.


Are there limits to the salary and fringe amounts that can be budgeted?
Yes, there are limits for the postdoc phase and faculty phase of the award.

If the awardee elects to utilize the postdoctoral portion of the award (up to two years of support) A maximum of $90,000 may be used for salary and fringe benefits combined during year one of the postdoctoral phase. A maximum of $95,000 may be used for salary and fringe benefits combined during year two of the postdoctoral phase.

During the faculty portion of this award, a maximum of $59,500 may be used annually towards the named investigators salary and fringe benefits combined.


Can caregiver expenses be budgeted?
Yes, up to $5,000/year may be applied towards caregiving expenses. This is separate from the salary and fringe limits. This benefit can be utilized during any portion of the award.


Are there font or margin requirements for the research plan?
Yes. Use standard 11- or 12-point type for the text and no smaller than 9 to 10-point type for figures, legends, and tables. The text must be single-spaced, with one inch or larger margins. The font size requirement is strictly enforced.

Application

Is the BWF application deadline firm?
Yes.


Can I submit a paper application?
No. BWF requires that all applications for this program be submitted electronically by the application deadline. Paper applications will not be accepted.


Can I submit more than one application?
No.


Can I change my application once it is submitted?
No. Once your application is submitted, it cannot be changed.


What is a “signature block”?
A signature block is found at the end of a letter and includes the letter writer’s name, title(s), department(s), and institution. It is usually found just after the closing of the letter (e.g., just after the word ‘Sincerely,’ or ‘Yours truly,’) and just under the letter writer’s signature. Here is an example of a signature block:

Jane Smith, M.D., Ph.D.
Chair and Professor, Department of Medicine
ABC University  


Do I need to complete an application in one session?
No, you can start an application and return later to complete it. When beginning a new application, you are required to log in with an existing or established proposal central log-in and password. You can save, exit the application, and return later at any time during the application process.


I forgot my user ID and/or password. What should I do?
If you have forgotten your password or user ID, visit the BWF grant application system and click the forgotten password link.


What is the Signature Page Form? How do I submit it?
The Signature Page Form provides a signature line for the Applicant. An application is not considered complete without the Signature Page form. You must upload the completed Signature Page form with your signature by the application deadline date.An emailed, mailed, or faxed signature page will not be accepted.  


What is the Institutional Certification Form? How do I submit it?
It is a required form that must be completed and signed by an authorized signing official to certify (a) the university’s non-profit status as a degree-granting institution and (b) the applicant meets all eligibility and residency requirements for the CAMS program at the submission deadline. An application is not considered complete without the Institutional Certification form. An emailed, mailed, or faxed institutional certification form will not be accepted.

Award Logistics

Can I change institutions during the award?
The award is portable.  Most awardees will change institutions to begin a faculty appointment. However, transferring your award is not guaranteed. The institution that you wish to transfer to must demonstrate a commitment to you by offering you a tenure track or equivalent faculty appointment and significant start-up money. In addition, BWF must approve the transfer. Transfers during the faculty portion of the award are discouraged.


Can I interrupt the award because of family commitments?
Yes.  BWF will allow you a no-cost extension of up to two years during the award term.


Are awardees permitted to receive other simultaneous funding, such as from the National Institutes of Health or another foundation?
Award recipients may obtain funds from other sources for research in the same or similar areas as that conducted under these grants, so long as there is no conflict with meeting the terms of BWF’s award. Award recipients may not hold concurrent BWF awards or NIH K99/R00, NIH DP5, or similar Early Independence awards.


What are my chances of receiving a Career Award for Medical Scientists?
There is no way to know definitively how many proposals we will receive each application cycle and, therefore, what the success rate will be. However, based on data from previous CAMS competitions, we estimate an award rate of 12 percent.

 Updated: 30 September 2025 

2025

Anand Bhagwat, MD, PhD
Children’s Hospital of Philadelphia
Novel mechanisms of acute myeloid leukemia resistance to cell therapy
 
Aaron Bodansky, MD
University of California-San Francisco
Overcoming Pediatric Viral-Induced Critical Illness
 
Walter Chen, MD, PhD
University of Texas Southwestern Medical Center
Defining the functions of uncharacterized organellar proteins
 
Nicolas Gomez-Banoy, MD
Rockefeller University
Unraveling genetic determinants of thermogenic adipose tissue in humans
 
Max Horlbeck, MD, PhD
Boston Children’s Hospital
Mechanisms and treatability of neurodevelopmental disorders of chromatin biology
 
Peggy Hsu, MD, PhD
University of Michigan
On the origin of ALK-driven lung cancer
 
Sakeen Kashem, MD, PhD
University of California-San Francisco
Immunological modulation of pain
 
Kaitlin Katsura, DDS, PhD
Children’s Hospital of Philadelphia
Macrophages in tooth development
 
Sumeet Khetarpal, MD, PhD
Massachusetts General Hospital
Mining and modulating the heart secretome of exercise for therapeutic gain in heart failure
 
John Pluvinage, MD, PhD
University of California-San Francisco
Autoimmune Regulation of Cognition in Encephalitis, Neurodegeneration, and Aging
 
Tara Reid, MD, PhD
University of Washington
Define the role of Treponema pallidum-specific humoral responses during infection
 
Eric Song, MD, PhD
Yale University
Lymphatic control of neural and ocular immune responses
 
Sarah Urbut, MD, PhD
Massachusetts General Hospital
Bayesian Mixture Models for Genetic Discovery of Complex Disease over Time

2024

Alan Baik, MD
University of California – San Francisco
Inspiration from Yeast: SREBP1 as an Evolutionarily Conserved Oxygen Sensor
 
Sagar Bapat, MD, PhD
University of California – San Francisco
Nutritional Control of the Immune Response
 
Shinnyi Chou, MD, PhD
University of Pittsburgh
Terminal type-specific cannabinoid CB1 receptor alterations in schizophrenia and cannabis use
 
Geon Kim, MD
Dana–Farber Cancer Institute
Targeting metabolic vulnerabilities in clonal hematopoiesis
 
Yonit Lavin, MD, PhD
Memorial Sloan Kettering Cancer Center
Exploring the Impact of Macrophages in Squamous Cell Carcinoma’s Invasive Front
 
June-Koo Lee, MD, PhD
Memorial Sloan Kettering Cancer Center
Tracking Genomic Evolution and Therapeutic Implication of Oncogene Amplification in Cancer
 
Salvador Alonso Martinez, MD
Memorial Sloan Kettering Cancer Center
Detecting and targeting therapy-resistant cancer cell states
 
Gunes Parlakgul, MD
University of California – Berkeley
Deciphering the role of Endoplasmic Reticulum structure in fatty liver disease
 
Sydney Ramirez, MD, PhD
La Jolla Institute for Immunology University of California – San Diego
Implications of upper airway adaptive immune memory in vaccine responsiveness and protection from respiratory pathogens
 
Theodore Roth, MD, PhD
Stanford University
Personalized synthetic immune cell engineering across diverse cancer patients
 
Rachel Wolfson, MD, PhD
Massachusetts General Hospital
The role of upper gastrointestinal tract innervating mechanosensory DRG sensory neurons in controlling motility and feeding behavior
 
Peng Wu, MD, PhD
Stanford University
Lineage programs that promote tumorigenesis in the developing liver
 
Gloria Yiu, MD, PhD
University of California – Los Angeles
Dynamic FOXP3 Expression in the Development of Regulatory T cells from Induced Pluripotent Stem Cells

2023

Maria Basil MD, PhD
University of Pennsylvania
The Molecular Regulation of a Novel Distal Airway Progenitor in COPD
 
Glynnis Garry MD
University of Texas Southwestern Medical Center-Dallas
The Role for PHF7 in Adult Fibroblast to Cardiomyocyte Reprogramming
 
Sattar Khoshkhoo MD
Harvard Medical School
Developmental Origins and Molecular Mechanisms of Somatic Mutations in Mesial Temporal Lobe Epilepsy
 
Paulo Lizano MD, PhD
Beth Israel Deaconess Medical Center
Blood-Brain Barrier Disruption as a Biomarker for Early Course Psychosis: An In Vivo/Ex Vivo Investigation
 
Anish Mitra MD, PhD
Stanford University
Cognitive and Circuit Mechanisms Underlying Spontaneous Cortical States
 
Jacqueline Parchem MD
University of Texas-Houston Health Science Center
Maternal COVID-19 and Placental Mechanisms of Preeclampsia
 
Sheila Shanmugan MD, PhD
University of Pennsylvania
Using person-specific networks to uncover sex differences in vulnerability to internalizing symptoms
 
Diana Shi, MD
Harvard Medical School
Molecular Dynamics of Glioma Formation and DNA Damage Response by Mutant IDH1
 
Joelle Straehla MD
Massachusetts Institute of Technology
Biologic regulators: a paradigm shift for cancer nanomedicine
 
Brian Sweis MD, PhD
Icahn School of Medicine at Mount Sinai
Neuroeconomic investigation of the computational and molecular mechanisms underlying depression
 
Samuel Weinberg MD, PhD
Northwestern University
The Role of Dendritic Cell Metabolism in Regulating Adaptive Immune Responses
 
Samir Zaidi MD PhD
Memorial Sloan-Kettering Cancer Center
Reprogramming Drug Resistance in Cancer Cells

2022

Alice Cheng, MD, PhD
Stanford University
Engineering a synthetic microbial community for research and treatment of Nonalcoholic steatohepatitis
 
Theodore George Drivas, MD, PhD
University of Pennsylvania
Discovering molecular and genetic mechanisms of ciliary signaling in common disease
 
William Allen Freed-Pastor, MD, PhD
Harvard Medical School
Overcoming T cell exclusion to augment immunotherapy in pancreatic cancer
 
Alexander Gitlin, MD, PhD
Stanford University
Insights from complex immune disorders: how an apoptotic caspase unleashes inflammation
 
Gil Hoftman, MD, PhD
University of California-Los Angeles
Imaging transcriptomics across developmental stages of early psychotic illness
 
William L Hwang, MD, PhD
Harvard Medical School
Identifying key regulators of the neuronal-like malignant phenotype and tumornerve crosstalk in pancreatic cancer
 
Maya Evelyn Kotas, MD, PhD
University of California-San Francisco
Understanding the role of tuft cells in allergic airway disease
 
Juan Carlos Osorio, MD
Memorial Sloan-Kettering Cancer Center
Optimization of Fc Effector Activity of Anti-CD47 Antibodies for Cancer Immunotherapy
 
Kartik Pattabiraman, MD, PhD
Yale University
Developmental disruption of prefrontal circuits as the neurodevelopmental etiology of schizophrenia
 
Jessica Renee Queen, MD, PhD
Johns Hopkins University School of Medicine
A Microbiota-Induced Switch to Immune Checkpoint Inhibitor Responsiveness in Colon Cancer
 
Carolyn Sangokoya, MD, PhD
University of California-San Francisco
Illuminating post-transcriptional control of stem cell fate and function
 
Jay Sarthy, MD, PhD
Fred Hutchinson Cancer Research Center
Interrogation of Pathological Histone Dynamics to Identify Drivers of Tumor Heterogeneity and Therapeutic Vulnerabilities
 
Christina Theodoris, MD, PhD
Harvard Medical School
Transfer learning leveraging large-scale single cell transcriptomics to enable predictions in settings with limited data
 
Josephine Wanjiru Thinwa, MD, PhD
University of Texas Southwestern Medical Center-Dallas
The Function of CDKL5 in autophagy and host antiviral defense

2021

Serine Avagyan, MD, PhD
Dana-Farber | Boston Children’s Hospital Cancer and Blood Disorders Center
Hematopoietic stem cell clonal diversity in GATA2 deficiency associated blood disorders
 
David Benjamin Beck, MD, PhD
National Institutes of Health (NIH)*
Understanding the Role of Somatic Mutations in Severe Adult-Onset Inflammatory Diseases
*Funding will be received by faculty institute TBD
 
Silvia Bernardi, MD
Columbia University
Neural bases of conceptual generalization and transfer learning: mechanisms that go awry in psychiatric illness
 
Jeeyeon Monica Cha, MD, PhD
Vanderbilt University
Understanding sexually dimorphic responses of the pancreatic beta cell in diabetes
 
Raghu Ram Chivukula, MD, PhD
Massachusetts Institute of Technology
Elucidating the Role of Lysosome Dysfunction in Pulmonary Fibrosis
 
Carlos Antonio Diaz-Balzac, MD, PhD
University of Rochester
Transcriptional regulation of neural circuit formation in intellectual disabilities
 
Neir Eshel, MD, PhD
Stanford University
Dopamine and serotonin at the intersection of reward and aggression
 
Russell Paul Goodman, MD, DPhil
Massachusetts General Hospital
Targeting Hepatic Reductive Stress to Treat Fatty Liver Disease
 
Brian Christopher Miller, MD, PhD
Dana-Farber Cancer Institute
Targeting Myeloid Cells as a Personalized Immunotherapy Approach to Cancer
 
Rachel Niec, MD, PhD
Rockefeller University
Lymphatic regulation of the intestinal stem cell niche
 
Celestine N. Wanjalla, MD, PhD
Vanderbilt University
Understanding the role of CD4+ T helper cells in cardiovascular disease progression in persons with HIV
 
Kevin Wei, MD, PhD
Brigham and Women’s Hospital
Notch3 as a therapeutic target in rheumatoid arthritisM

2020

Alexander George Bick, MD, PhD
Harvard Medical School
Targeting clonal hematopoiesis using human genetics
 
Julia Catherine Carnevale, MD
University of California-San Francisco
Targeting SOCS1 and RASA2 to engineer more potent adoptive T cell therapies for cancer treatment
 
Erin Conrad, MD
University of Pennsylvania
Using EEG network alterations to diagnose epilepsy
 
Emily Anne Ferenczi, MB, ChB, PhD
Harvard Medical School
Direct projections from globus pallidus externa (GPe) to cortex: a novel role in basal ganglia-cortical circuit function
 
Ryan Alexander Flynn, MD, PhD
Stanford University
Defining the regulation of RNA by glycosylation
 
Anna Nam, MD
Weill Medical College of Cornell University
Defining the impact of somatic mutations on human hematopoiesis via single-cell multi-omics
 
Josephine Ni, MD
University of Pennsylvania
Determinants of bacterial biofilm formation at the intestinal mucosal interface and their roles in pathogen exclusion
 
Xilma Rosa Ortiz-Gonzalez, MD, PhD
University of Pennsylvania
Looking at Neuroegenerative Disorders Through a Pediatric Lens
 
William Renthal, MD, PhD
Harvard Medical School
Leveraging single-cell genomics for the development of novel pain treatments
 
Andrew Ben Stergachis, MD, PhD
Harvard Medical School
Single-molecule chromatin architectures of disease-associated non-coding genetic variants

2019

Jonathan R Brestoff, MD, PhD
Washington University
Role of Cell-to-Cell Transfer of Mitochondria in Regulating Metabolism
 
Gaurav Das Gaiha, DPhil, MD
Harvard Medical School
Using Network Theory to Suppress the Latent HIV-1 Reservoir
 
Karuna Ganesh, MD, PhD
Memorial Sloan-Kettering Cancer Center
Emergence of Regenerative Plasticity in Metastasis Stem Cells
 
Wei Gu, MD, PhD
University of California-San Francisco
Modeling Pathogen Cell-free DNA Dynamics in Acute Infections
 
Marie A Guerraty, MD, PhD
University of Pennsylvania
The interplay between cardiomyocyte FOG2 and HIF pathway in Coronary Microvascular Disease
 
Rodney Infante, MD, PhD
University of Texas Southwestern Medical Center-Dallas
Regulation of Cancer Cachexia Wasting by a Tumor-Adipose-Hypothalamic Axis
 
Michael George Kattah, MD, PhD
University of California-San Francisco
A20 and ABIN-1 cooperatively preserve intestinal integrity
 
Corey Keller, MD, PhD
Stanford University
Closing the loop: development of real-time, personalized brain stimulation
 
Robert M Samstein, MD, PhD
Memorial Sloan-Kettering Cancer Center
Immunogenicity of Homologous Recombination Defects and Response to Immunotherapy
 
Ashley Steed, MD, PhD
Washington University
Regulation of Host Immunity via Microbially-derived Metabolites
 
Santosha A. Vardhana, MD, PhD
Memorial Sloan-Kettering Cancer Center
Investigating metabolic susceptibilities of exhausted T-cells
 
Andrew Sean Venteicher, MD, PhD
University of Pittsburgh
Uncovering drivers of immortality in human CNS tumors
 
Doris Du Wang, MD, PhD
University of California-San Francisco
Using adaptive neurostimulation to understand and enhance motor skill learning in Parkinson’s Disease

2018

Samuel F Bakhoum, M.D., Ph.D.
Memorial Sloan-Kettering Cancer Center
Probing the role of chromosomal instability in tumor evolution
 
Elizabeth Joyce Bhoj, M.D., Ph.D.
University of Pennsylvania
A novel pediatric neurodegenerative disorder caused by histone 3.3 mutations: unique insights into the histone code
 
Hsiao-Tuan Chao, M.D., Ph.D.
Baylor College of Medicine
Mechanisms of COE-transcriptional dysfunction in neurodevelopmental disorders
 
Keira Alexis Cohen, M.D.
Johns Hopkins University School of Medicine
Genomic analysis of drug resistance determinants in nontuberculous mycobacteria
 
John Gordan, M.D., Ph.D.
University of California-San Francisco
Targeting viral mechanisms of oncogenesis in liver cancer
 
Sarah Emily Henrickson, M.D., Ph.D.
University of Pennsylvania
Directly interrogating mechanisms of human T cell dysfunction in the setting of chronic inflammation and atopy
 
Benjamin Izar, M.D., Ph.D.
Harvard Medical School
Functional validation of resistance mechanisms to immunotherapies at single-cell resolution
 
Corrine RaShelle Kliment, M.D., Ph.D.
Johns Hopkins University
The role of adenine nucleotide translocase in the protection of airway epithelial cells in Chronic Obstructive Pulmonary Disease (COPD)
 
Albert Russell Powers, M.D., Ph.D.
Yale University School of Medicine
Computational markers for psychosis: toward early diagnosis and intervention
 
Deepak Angara Rao, M.D., Ph.D.
Harvard Medical School
Peripheral helper T cells in autoimmunity
 
Ansuman Satpathy, M.D., Ph.D.
Stanford University
Epigenetic mechanisms of immunotherapy resistance in tumor-specific T cells
 
Mark A Sellmyer, M.D., Ph.D.
University of Pennsylvania
Engineering digital logic for cell-cell interactions
 
Tanya Sippy, M.D., Ph.D.
New York University
Reward processing in striatal projection neurons during goal directed behaviors

2017

Vijay Garud Bhoj, M.D., Ph.D.
University of Pennsylvania
Development of CAR T-cell immunotherapy for prevention and eradication of FVIII inhibitors in Hemophilia A
 
Lindsay Catherine Burrage, M.D., Ph.D.
Baylor College of Medicine
Impaired glycogen metabolism and chronic liver disease in urea cycle disorders
 
Aaron Foster Carlin, M.D., Ph.D.
University of California-San Diego
Deciphering human innate immune responses to Zika virus infection
 
Alejandro Chavez, M.D., Ph.D.
Harvard Medical School
Novel technologies and their application to neurodegenerative diseases
 
Whitney Elizabeth Harrington, M.D., Ph.D.
University of Washington
Defining the role of maternal cells in fetal and infant immunity to malaria
 
Tamia Alisha Harris-Tryon, M.D., Ph.D.
University of Texas Southwestern Medical Center-Dallas
The Function of Resistin Like Molecule alpha (RELMalpha) in Cutaneous Host Defense
 
Kara Noelle Maxwell, M.D., Ph.D.
University of Pennsylvania
A genotype-phenotype study of tumors from patients with inherited mutations in DNA repair genes
 
Kent William Mouw, M.D., Ph.D.
Harvard Medical School
Investigating the effect of ERCC2 mutations on DNA repair capacity and chemo-radiotherapy response in muscle-invasive bladder cancer
 
Anoop Patel, M.D.
University of Washington
Deep interrogation and modeling of intratumoral heterogeneity, plasticity, and tumor evolution in glioblastoma
 
Tamer Sallam, M.D., Ph.D.
University of California-Los Angeles
Spatial control of nuclear receptor regulatory circuits in cardiovascular disease
 
Zuzana Tothova, M.D., Ph.D.
Harvard Medical School
Elucidating the mechanisms of cohesinopathy in myelodysplastic syndromes
 
Craig Brian Wilen, M.D., Ph.D.
Washington University
Role of virus-receptor interactions in determining norovirus tropism and pathogenesis

2016

Jonathan Abraham, M.D., Ph.D.
Harvard Medical School
Profiling the human antibody response in survivors of viral hemorrhagic fevers
 
Heidi Leigh Cook-Andersen, M.D., Ph.D.
University of California-San Diego
Post-transcriptional gene regulation during the mammalian oocyte-to-embryo transition
 
Mariella Gruber Filbin, M.D., Ph.D.
Harvard Medical School
Discovering novel epigenetic dependencies in pediatric high-grade glioma
 
Andrew Michael Intlekofer, M.D., Ph.D.
Memorial Sloan-Kettering Cancer Center
Investigating L-2-hydroxyglutarate production and its relevance to normal hematopoiesis and leukemogenesis
 
Siddhartha Jaiswal, M.D., Ph.D.
Harvard Medical School
Elaborating the causal link between clonal hematopoiesis and atherosclerosis
 
Devanand Sadanand Manoli, M.D., Ph.D.
University of California-San Francisco
Genetic models of social attachment in development and mental illness
 
Alexander Marson, M.D., Ph.D.
University of California-San Francisco
Molecular characterization of non-coding genetic variants that promote human autoimmunity
 
Seth Rakoff-Nahoum, M.D., Ph.D.
Harvard Medical School
Gut microbiota ecological interaction networks in health and disease
 
Dhakshin Ramanathan, M.D., Ph.D.
University of California-San Francisco
Role of spindle oscillations in modulating neural plasticity and procedural memory consolidation
 
Tiffany Crawford Scharschmidt, M.D.
University of California-San Francisco
Elucidating mechanisms of immune tolerance to skin commensal bacteria
 
Alexander Spektor, M.D., Ph.D.
Harvard Medical School
The mechanism of DNA damage and chromothripsis from chromosome segregation errors
 
Bruce Mao Zheng Wang, M.D.
University of California-San Francisco
Wnt signaling and hepatocyte stem cells in liver homeostasis and cancer

2015

Jennifer M Alexander-Brett, M.D., Ph.D.
Washington University
Targeting the Regulatory Mechanism of the Nucleokine IL-33
 
Daniel Evan Bauer, M.D., Ph.D.
Harvard Medical School
Functional Characterization of Trait-Associated Enhancers
 
James Toliver Bennett, M.D., Ph.D.
University of Washington
Impact of Somatic Mutations on Birth Defects
 
Shadmehr Demehri, M.D., Ph.D.
Harvard Medical School
Local and Systemic Effects of TSLP on Cancer
 
Charles Gawad, M.D.
University of Tennessee Health Science Center College of Medicine
Defining the Cellular and Genetic Origins of Childhood Acute Lymphoblastic Leukemia using Single-Cell Genomics
 
Matthew Blake Greenblatt, M.D., Ph.D.
Weill Cornell Medical College
Novel Mechanisms of Bone Formation
 
Rajan Jain, M.D.
University of Pennsylvania Perelman School of Medicine
Nuclear lamina-chromatin interactions are drivers of cardiac progenitor cell commitment
 
Matthew Stern Kayser, M.D., Ph.D.
University of Pennsylvania Perelman School of Medicine
A role for sleep in synapse development and susceptibility to neuropsychiatric disorders
 
Dan Avi Landau, M.D., Ph.D.
Weill Cornell Medical College
Genetic and Epigenetic Determinants of Chronic Lymphocytic Leukemia Evolution
 
Kory Joshua Lavine, M.D., Ph.D.
Washington University School of Medicine
Distinct Macrophage Lineages Govern Cardiac Recovery and Heart Failure Progression
 
Bluma J. Lesch, M.D., Ph.D.
Massachusetts Institute of Technology
Evolutionary and functional characterization of poised chromatin in the mammalian germ line
 
Joseph Douglas Mancias, M.D., Ph.D.
Harvard Medical School
Role of ferritinophagy in iron metabolism and pancreatic cancer
 
Anna Victoria Rotberg Molofsky, M.D., Ph.D.
University of California-San Francisco
Astrocyte-Encoded Regional cues in Developmental Synapse Formation
 
Sahar Nissim, M.D., Ph.D.
Harvard Medical School
Discovery, Validation, and Characterization of Novel Familial Pancreatic Cancer Genes

2014

Theresa Alenghat, D.V.M., Ph.D.
University of Cincinnati
Epigenomic regulation of the host-commensal relationship
 
Christina Eleanor Barkauskas, M.D.
Duke University
Epithelial-mesenchymal crosstalk in lung fibrosis and alveolar homeostasis
 
James Edward Cassat, M.D., Ph.D.
Vanderbilt University School of Medicine
The contribution of host and pathogen to altered bone homeostasis and bacterial survival during overseas
 
Kevin Jon Cheung, M.D.
Johns Hopkins University
Elucidating the role of K14+ leader cells in breast cancer invasion and metastasis
 
Ethan Michael Goldberg, M.D., Ph.D.
University of Pennsylvania Perelman School of Medicine
Analysis of circuit function informs novel therapeutic interventions in an epilepsy model
 
Malay Haldar, M.D., Ph.D.
Washington University School of Medicine
Transcription factor SPI-C at the interface of iron homeostasis and innate immunity
 
Marcin Imielinski, M.D., Ph.D.
Harvard Medical School
Reconstructing complex loci in lung adenocarcinoma with large-insert whole genome sequencing
 
Jeffery M Klco, M.D., Ph.D.
University of Tennessee
Role of notch signaling in the bone marrow stroma
 
Jason Knight, M.D., Ph.D.
University of Michigan-Ann Arbor
Innate immunity in the pathogenesis of lupus and antiphospholipid vasculopathy
 
Anita Katherine McElroy, M.D., Ph.D.
Emory University School of Medicine
Defining the roles of CD4+ T cells in generating a protective immune response against Rift Valley fever virus
 
Sudarshan Rajagopal, M.D., Ph.D.
Duke University Medical Center
Dissecting receptor Signaling pathways in pulmonary hypertension
 
Sean Robinson Stowell, M.D., Ph.D.
Emory University School of Medicine
Elucidating mechanisms of innate immunity against molecular mimicry

2013

Susanne Elizabeth Ahmari, M.D., Ph.D.
Columbia University
Testing the Role of Cortico-Striatal Circuits in Obsessive Compulsive Disorder Pathology and Treatment
 
Gautam Bhave, M.D., Ph.D.
Vanderbilt University Medical Center
Role of Peroxidasin and Protein Halogenation in Diabetic Nephropathy
 
Ajai Arvind Dandekar, M.D., Ph.D.
University of Washington
Quorum sensing and mechanisms to ensure cooperation in the opportunistic pathogen Pseudomonas aeruginosa
 
Andrew Eugene Hermann Elia, M.D., Ph.D.
Harvard Medical School
Proteomic analysis of ubiquitination and protein stability in the DNA damage response
 
Gaorav P Gupta, M.D., Ph.D.
Memorial Sloan-Kettering Cancer Center
DNA Damage Responses in Breast Cancer Pathogenesis
 
Andrew Caleb Hsieh, M.D.
University of California-San Francisco
Elucidating the role of aberrant translational control on prostate cancer invasion and metastasis
 
Jean-Sebastien Joyal, M.D., Ph.D.
University of Montreal Faculty of Medicine
Neuronal Energy Metabolism Drives Angiogenesis
 
Alex Kentsis, M.D., Ph.D.
Harvard Medical School
Tumorigenesis by endogenous DNA transposons in human cancer.
 
Jeniel Emily Nett, M.D., Ph.D.
University of Wisconsin-Madison
Mechanisms of Candida Biofilm Immune Evasion
 
Rhea Myers Sumpter, Jr., M.D., Ph.D.
University of Texas Southwestern Medical Center-Dallas
A novel role for FANCC in selective autophagy

2012

Chetan Bettegowda, M.D., Ph.D.
Johns Hopkins University
Translational molecular profiling of oligodendrogliomas
 
Scott Richard Floyd, M.D., Ph.D.
Massachusetts Institute of Technology
Insulating chromatin from DNA damage signaling: epigenetic modifications and connections to human cancer
 
Benjamin Elison Gewurz, M.D., Ph.D.
Harvard Medical School
Identification of novel NFkB pathway components important for lymphomagenesis
 
Michael Rosenblum, M.D., Ph.D.
University of California-San Francisco
Memory regulatory T cells in inflammatory and autoimmune disease
 
Michael Thomas Spiotto, M.D., Ph.D.
University of Chicago
Identification of chromosomal aberrations that cooperate with the human papillomavirus to cause cancer
 
David Tsai Ting, M.D.
Harvard Medical School
Characterization of non-coding RNAs in pancreatic adenocarcinoma
 
Richard Chih-Chien Wang, M.D., Ph.D.
University of Texas Southwestern Medical Center-Dallas
Akt-mediated regulation of autophagy & tumorigenesis through formation of a beclin 1/keratin intermediate filament complex
 
Kelley Yan, M.D., Ph.D.
Stanford University
Regulation of active and quiescent intestinal stem cells
 
Ellen Yeh, M.D., Ph.D.
Stanford University
Function of the plastid organelle in P. falciparum: beyond isoprenoid precursor biosynthesis and blood stage
 
Hao Zhu, M.D.
Harvard University
Investigating the Lin28/let-7 pathway in mouse models of liver cancer and regeneration

Geoffrey Aguirre, MD, PhD (Co-Chair)
Professor of Neurology
Department of Neurology
University of Pennsylvania Medical School
BWF Career Awardee in the Biomedical Sciences – 2004

 

Susanne Ahmari, MD, PhD
Associate Professor of Psychiatry
Director, Translational OCD Laboratory
Department of Psychiatry
University of Pittsburgh
BWF Career Awardee for Medical Scientists – 2013

 

Mary Armanios, MD
Professor of Oncology, Genetic Medicine and Pathology
Director, Telomere Center at Johns Hopkins
Johns Hopkins School of Medicine

 

Chester W. Brown, MD, PhD
St. Jude Chair of Excellence in Genetics
Professor of Genetics
Department of Pediatrics
University of Tennessee Health Science Center
BWF Career Awardee in the Biomedical Sciences – 2000

 

Kathleen H. Burns, MD, PhD
Professor & Department Chair of Pathology
Dana-Farber Cancer Institute
Professor of Pathology
Harvard Medical School
BWF Career Awardee for Medical Scientists – 2008

 

Trevor Burt, MD
Associate Professor of Pediatrics
Department of Pediatrics
Duke University School of Medicine

 

Jeanine D'Armiento, MD, PhD
Director of the Center for Molecular Pulmonary Disease in Anesthesiology and Physiology and Cellular Biophysics
Director, Center for LAM and Rare Lung Disease
Professor of Medicine in Anesthesiology
Columbia University
BWF Career Awardee in the Biomedical Sciences – 1996

 

Anna Huttenlocher, MD
Professor of Medical Microbiology & Immunology and Pediatrics
University of Wisconsin School of Medicine and Public Health

 

Nicola Jones, MD, PhD
Director, Integrated Physician Scientist Training Program
Professor of Pediatrics and Physiology
Temerty Faculty of Medicine
University of Toronto

 

Phyllis Kanki, DVM, ScD
Mary Woodard Lasker Professor of Health Sciences
Department of Immunology & Infectious Disease
Harvard T H Chan School of Public Health
Harvard University

 

Annet Kirabo, DVM, PhD
Associate Professor of Medicine, Division of Clinical Pharmacology
Associate Professor of Molecular Physiology and Biological Physics
Vanderbilt University

 

Wilbur Lam, MD, PhD
Professor and W. Paul Bowers Research Chair
Department of Pediatrics and the Wallace H. Coulter Department of Biomedical Engineering
Aflac Cancer and Blood Disorders Center at Children’s Healthcare of Atlanta
Emory University

 

Heather C. Mefford, MD, PhD (Co-Chair)
Full Member of the Center for Pediatric Neurological Disease Research
Department of Cellular and Molecular Biology
St. Jude Children's Research Hospital
BWF Career Awardee for Medical Scientists – 2008

 

Markus Müschen, MD, PhD
Arthur H. and Isabel Bunker Professor of Hematology
Professor of Immunobiology
Director, Center of Molecular and Cellular Oncology
Yale University

 

Maureen Su, MD
Morrison Family Endowed Chair
Professor of Microbiology, Immunology, and Medical Genetics
Department of Pediatrics (Endocrinology)
University of California Los Angeles

 

Alik Widge, MD, PhD
Associate Professor of Psychiatry & Behavioral Sciences
University of Minnesota

 

Weiping Zou, MD, PhD
Professor of Pathology, Immunology, Biology, and Surgery
Director, Center of Excellence for Cancer Immunology and Immunotherapy
University of Michigan

 

Additional members may be added to the committee.

Award Timeline

Oct 07, 2025

Application Deadline

Mar 17 - 18, 2026

Finalist virtual interviews

Jun 18, 2026

Notice of Award

Sep 01, 2026

Award Start Date

Aug 31, 2031

Award End Date

Program Contacts

Paige Cooper Byas, PhD

Program Officer

919-991-5127

Daniel Baroff

Program Associate

919-991-5133

Lama Haidar

Program Coordinator

919-991-5115